Henry Schein Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Henry Schein hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

3.9%

Rückkaufsrendite

Gesamte Aktionärsrendite	3.9%
Zukünftige Dividendenrendite	0%
Wachstum der Dividende	n/a
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Ausschüttungsquote	n/a

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Henry Schein: Another Day, Another Purchase

Nov 20

Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings

Nov 13

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Oct 11

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Sep 23

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von HSIC in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von HSIC gestiegen sind.

Dividendenrendite im Vergleich zum Markt

Henry Schein Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von HSIC im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (HSIC)	n/a
Untere 25 % des Marktes (US)	1.4%
Markt Top 25 % (US)	4.2%
Branchendurchschnitt (Healthcare)	1.6%
Analystenprognose (HSIC) (bis zu 3 Jahre)	0%

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von HSIC im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von HSIC im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von HSIC, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da HSIC keine Ausschüttungen gemeldet hat.

Henry Schein Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Recent updates

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire Acentus.

Henry Schein: Another Day, Another Purchase

Ananym Capital Management Pushes for Changes at Henry Schein

Ananym Capital Management Pushes for Changes at Henry Schein

Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Updates Earnings Guidance for the Full Year 2024

Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q3, 2024 Results on Nov 05, 2024

Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from FTSE All-World Index (USD)

Price target decreased by 7.7% to US$73.27

Insider recently sold US$1.5m worth of stock

Insider notifies of intention to sell stock

Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Consensus EPS estimates fall by 12%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Independent Director recently sold US$148k worth of stock

Senior VP & Chief Legal Officer notifies of intention to sell stock

Independent Lead Director recently sold US$504k worth of stock

Independent Lead Director notifies of intention to sell stock

Independent Director recently sold US$923k worth of stock